RedChip Issues Research Update on Lattice IncorporatedQuadrant 4 to Present at LD Micro Conference on December 3Opexa Therapeutics Selected as One of the "Top 10 Advanced Therapy Projects to Watch"RedChip Issues Research Update on Akers BiosciencesOxySure Systems - Defining New Large Markets with No Direct Competition
"RedChip has been instrumental in raising our profile among both savvy institutional investors and retail investors that are looking for differentiated and unique companies. RedChip has developed a unique combination of providing targeted media exposure and investor relations support for emerging companies."
Panna Sharma, CEO of Cancer Genetics, Inc. (NasdaqCM: CGIX)
"I have appeared on the RedChip Money Report TV show four times. Dave Gentry, the host, is professional and engaging. I strongly recommend this show for CEOs who want exposure to thousands of microcap investors. There is a very tangible benefit of appearing on RedChip's 'Small Stocks, Big Money."
Jim Czirr, CEO of Galectin Therapeutics, Inc.
"I value our relationship with RedChip. I have nothing but praise for the RedChip team. Their platform is innovative and effective. I strongly recommend them for any serious smaller-cap company that needs exposure to Wall Street's institutional and retail investor community."
Semyon Dukach, Chairman SMTP INC
"Whether delivered over Skype or live from the Orlando studios or during a conference -- RedChip has helped increase awareness of Lightbridge's prospects as a developer of next-generation nuclear fuel technology and global advisory services. Moreover, we have been impressed by Dave Gentry's thorough grasp of our business model and his effective communication of our strategic goals.""
Seth Grae, President and CEO of Lightbridge Corp.
"I appreciate the RedChip team. They were the first investor relations firm to truly understand our story and position us properly to micro-cap investors. They seem to know all the small-cap investment banks, family offices and fund-managers that buy smaller companies. Their media platform is the best I have ever seen for companies with market caps of $500 million and under. I recommend them highly.""
DHRU Desai, Chairman-Quadrant 4 Systems
"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is discovering tomorrow's blue chips today."
Bob McCooey, Senior Vice President The NASDAQ Stock Market
"I am very pleased with RedChip. Their ability to generate quality one-on-one meetings with small-cap funds and retail brokers is impressive, particularly when matched with their research report and conference platform. I would strongly recommend them to any small-cap company listed or bulletin board who needs professional and systematic investor relations services."
Frank Jaksch, Co-Chairman/Founder and CSO, ChromaDex Corporation
RedChip's Exclusive Interview with Perritt Capital's Michael Corbett
Host Dave Gentry interviews Michael Corbett, CEO, CIO, and Portfolio Manager of Perritt Capital Management, an independent investment advisor that manages over $700 million in microcap and small-cap stocks. Watch Now
Dave Gentry Interviews Royce Funds' Bill Hench- RedChip Global Online CEO Conference
RedChip Money Report’s Dave Gentry talks with Royce Funds’ Bill Hench in this exclusive RedChip TV interview. Hench is portfolio manager of Royce Funds’ small-cap Opportunity Fund and Opportunity Select Fund." Watch Now
AVG A Leader in Online Security
Host Dave Gentry interviews John Little, CFO of AVG Technologies (NYSE:), The company offers various consumer suites for core protection, including anti-virus, anti-spyware, anti-rootkit, social networking protection, and LinkScanner.Watch Now
NetGear Global Leader in Internet Connectivity
Host Dave Gentry interviews Christine Gorjanc, Chief Financial Officer of NETGEAR, Inc (Nasdaq: NTGR), networking products for consumers, businesses, and service providers. The company operates in three segments: Retail, Commercial, and Service Provider. Watch Now
Opexa (OPXA) Developing MS Treatment in Partnership with Merck Serono
Host Dave Gentry interviews Neil Warma, CEO of Opexa Therapeutics (Nasdaq: OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), on "The RedChip Money Report: Small Stocks Big Money."Watch Now
Actinium Pharmeceuticals, Inc. (NYSE: ATNM)
A bio pharmaceutical company developing innovative targeted payload immuno-therapeutics for the treatment of advanced cancers. Watch Now
Quadrant 4 Systems, (QFOR): Emerging Growth Healthcare Exchange Platform
QFOR’s healthcare exchange platform (QHIX) projected to reach a yearly run rate of $48 million in revenue by end of 2014. Healthcare exchanges projected as a $2B-$6B market.Watch Now
Drone Aviation Corp. (DRNE): Cutting-Edge Drone Monitoring and Communication Technology
DRN's mission is to aggressively penetrate the expanding Drone market with our unique Tethered Drones, which are currently being fielded to the U.S. Department of Defense and State and Local municipalities. Watch Now
Akers Biosciences (NASDAQCM: AKER)
Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. Watch Now
(Nasdaq: TOPS) Top Ships, Inc: Money Report Interview - October 7, 2014 (Fox Business)
Host Dave Gentry interviews Alexandros Tsirikos, Chief Financial Officer of Top Ships, Inc (Nasdaq: TOPS), this company provides international seaborne transportation services carrying petroleum products and crude oil for the oil industry; and drybulk commodities for the steel, electric utility, construction, and agriculture-food industries. Watch Now
InterCloud (ICLD): Cloud-Solutions Provider Experiencing Rapid Revenue Growth
Dave Gentry interviews Mark Munro, CEO and President of InterCloud Systems, Inc. (NasdaqCM: ICLD), a cloud solutions company, on "The RedChip Money Report: Small Stocks Big Money."Watch Now
American Water Works (AWK): The Largest Publicly Traded U.S Water and Wastewater Utility Company
Host Dave Gentry interviews Edward Vallejo, Director of Investor Relations at American Water Works (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company on "The RedChip Money Report: Small Stocks Big Money." Watch Now
- EXEO: Company Fact Sheet
- GLYE: Research Profile - Nov. 2014
- LTTC: Research Profile - Nov. 2014
- QFOR: Research Profile - Nov. 2014
- OXYS: Research Profile - Nov. 2014
- ICLD: Research Profile - Nov. 2014
- AKER: Research Profile - Nov. 2014
- PFIE: Research Profile - Nov. 2014
- CGIX: Research Profile - Nov. 2014
- ATNM: Research Profile - Nov. 2014
- Tasman Files Annual Report on Form 20-F
- OxySure (OXYS) Is Undervalued and Has Crossed Above Its SqueezeTrigger Price
- RedChip Issues Research Update on GlyEco
- Golden State Water and California American Water Team up with State Assemblymember Ken Cooley for "Operation Gobble"
- California American Water Teams up with California State Senator Darrell Steinberg and Assemblymember Roger Dickinson for "Operation Gobble"